Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Communiqués de presse de la société JOHNSON & JOHNSON
01:09aJOHNSON & JOHNSON : Some Key Questions Answered On Covid-19 Vaccines for African..
AQ
01/18JOHNSON & JOHNSON : - DARZALEX FASPRO Becomes the First FDA-Approved Treatment f..
AQ
01/17FAUCI : U.S. 'weeks away' from evaluating new vaccine candidates
AQ
01/15JOHNSON & JOHNSON : DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) Become..
PU
01/15"MY 2021 HEALTHCARE RESOLUTION" : 7 Johnson & Johnson Leaders Share Their Goals ..
PU
01/14JOHNSON & JOHNSON : Statement on Political Contributions
PU
01/14NEXTECH AR : sees $7.3M in business for Q4
AQ
01/14Presidency On Africa Centres for Disease Control and Prevention Securing Firs..
AQ
01/14THE COVID-19 DATA PLAN : 3 Innovative Ways Johnson & Johnson Is Using Data Scien..
AQ
01/14270 Million Covid-19 Vaccine Doses Secured for Africa
AQ
01/13JOHNSON & JOHNSON : COVID-19 Vaccine Candidate Interim Phase 1/2a Data Published..
PU
01/13JOHNSON & JOHNSON : African Union buys 270 million vaccine doses for continent
AQ
01/13JOHNSON & JOHNSON : Janssen to Highlight Commitment to Lung Cancer Science and I..
AQ
01/12JOHNSON & JOHNSON : Janssen to Highlight Commitment to Lung Cancer Science and I..
PU
01/09The Cold Supply Chain Can't Reach Everywhere - That's a Big Problem for Equit..
AQ
01/08COVID-19 UPDATE : Your Latest Questions About Johnson & Johnson's Investigationa..
AQ
01/07The Vaccine Cold Supply Chain Can't Reach Everywhere
AQ
01/07JOHNSON & JOHNSON : Statement by Alex Gorsky Johnson & Johnson Chairman and CEO
AQ
01/04JOHNSON & JOHNSON : Announces Quarterly Dividend for First Quarter 2021
PR
2020JOHNSON & JOHNSON : Janssen Submits European Marketing Authorisation Application..
AQ
2020JOHNSON & JOHNSON : Disease-Free Survival Data from CAPTIVATE Study Demonstrate ..
PU
2020JOHNSON & JOHNSON : Updated Results from the Phase 1 Study of the BCMAxCD3 Bispe..
PU
2020JOHNSON & JOHNSON : Early, Deep, Durable Responses of Ciltacabtagene Autoleucel ..
PU
2020JOHNSON & JOHNSON : to Participate in the 39th Annual J.P. Morgan Healthcare Con..
PU
2020JOHNSON & JOHNSON : New Data Demonstrate Long-Term Benefit of IMBRUVICA® (ibruti..
PU
2020JOHNSON & JOHNSON : Janssen Submits Application to U.S. FDA Seeking Approval of ..
PU
2020BIOSTOCK : Iconovo address maternal health in partnership with Monash University
AQ
2020JOHNSON & JOHNSON : Janssen Initiates Rolling Submission of a Biologics License ..
AQ
2020JOHNSON & JOHNSON : Announces Agreement in Principle with Gavi to Supply Janssen..
AQ
2020JOHNSON & JOHNSON : to Host Investor Conference Call on Fourth-Quarter Results
AQ
2020JOHNSON & JOHNSON : Janssen Initiates Rolling Submission of a Biologics License ..
PU
2020ICONOVO : signs agreement for development of inhaled oxytocin in ICOone for mate..
AQ
2020JOHNSON & JOHNSON : Changing "Date Of Status" And "First Reported Date" May Expo..
AQ
2020JOHNSON & JOHNSON : WHO's COVID-19 vaccine drive doubles global supply to 2 bill..
AQ
2020JOHNSON & JOHNSON : to Host Investor Conference Call on Fourth-Quarter Results
PU
2020JOHNSON & JOHNSON : Announces Its First Phase 3 COVID-19 Vaccine Trial ENSEMBLE ..
AQ
2020JOHNSON & JOHNSON : Conference Chair from Johnson & Johnson Invites You to Atten..
AQ
2020JOHNSON & JOHNSON : Dow Jones, S&P 500 and Nasdaq Composite all hit record highs..
AQ
2020JOHNSON & JOHNSON : IP Rights Will Reduce Health Burden, Improve Economy, Expert..
AQ
2020XBRANE BIOPHARMA : Nina Ivers joins Xbrane Biopharma as Head of HR
AQ
2020JOHNSON & JOHNSON : to Participate in the 39th Annual J.P. Morgan Healthcare Con..
PU
2020OKLAHOMA ASKS COURT : Make J&J pay $9.3B to end opioid crisis
AQ
2020"WHAT IT'S LIKE TO BE IN A CLINICAL : 3 People Share Their Personal Stories
PU
2020JOHNSON & JOHNSON : Janssen Pharmaceutical Companies - New Data Demonstrate Long..
AQ
2020South Korea to begin COVID-19 vaccinations by March
AQ
2020JOHNSON & JOHNSON : - DARZALEX Data Show Deeper and Longer Responses in Patients..
AQ
2020JOHNSON & JOHNSON : - Data from the ANDROMEDA Study Show Hematologic Response fo..
AQ
2020JOHNSON & JOHNSON : Data from the ANDROMEDA Study Show Hematologic Response for ..
PU
2020JOHNSON & JOHNSON : Data from the APOLLO Study Show Clinically Meaningful Respon..
PU
2020JOHNSON & JOHNSON : New Data Demonstrate Long-Term Benefit of IMBRUVICA® (ibruti..
PU
2020JOHNSON & JOHNSON : Janssen Presents First Data from the Phase 1 Study of the GP..
PU
2020JOHNSON & JOHNSON : Updated Results from the Phase 1 Study of the BCMAxCD3 Bispe..
PU
2020JOHNSON & JOHNSON : Early, Deep, Durable Responses of Ciltacabtagene Autoleucel ..
PU
2020JOHNSON & JOHNSON : Disease-Free Survival Data from CAPTIVATE Study Demonstrate ..
PU
2020JOHNSON & JOHNSON : Janssen Submits Application to U.S. FDA Seeking Approval of ..
AQ
2020IMPACT DURING A PANDEMIC : 5 Ways Johnson & Johnson Was Recognized for Its COVID..
PU
2020JOHNSON & JOHNSON : Janssen Headlines American Society of Hematology Annual Meet..
PU
2020JOHNSON & JOHNSON : Change in Directors or Principal Officers (form 8-K)
AQ
2020JOHNSON & JOHNSON : Names Dr. Nadja West, retired United States Army lieutenant ..
PR
2020JOHNSON & JOHNSON : Announces Fireside Chat Webcast on Janssen's Eye Disease Por..
PU
2020HOFSETH BIOCARE ASA : HBC adds ex-Johnson & Johnson Senior Commercial leader, Wi..
AQ
2020JOHNSON & JOHNSON : European Commission Approves Janssen's TREMFYA®▼ (guse..
PU
2020JOHNSON & JOHNSON : New Survey Finds Critical Need for Education on Cataracts an..
PR
2020JOHNSON & JOHNSON : Janssen Pharmaceutical Companies - European Commission Appro..
AQ
2020JOHNSON & JOHNSON : Pfizer, and Merck Lost $3.5B in Combined YTD Revenue
AQ
2020JOHNSON & JOHNSON : Janssen Submits Paliperidone Palmitate 6-Month (PP6M) Supple..
PU
2020JOHNSON & JOHNSON : Initiates Second Global Phase 3 Clinical Trial of its Jansse..
PU
2020JOHNSON & JOHNSON : New XARELTO® (rivaroxaban) Peripheral Artery Disease (PAD) D..
PU
2020JOHNSON & JOHNSON : Janssen Submits Application to U.S. FDA for New Indication t..
PU
2020JOHNSON & JOHNSON : Late-Breaking 12-Month Data of Investigational RPGR Gene The..
PU
2020JOHNSON & JOHNSON : to Address Racial and Social Injustice through Platform that..
AQ
2020THE LATEST : British PM Johnson tests negative for virus
AQ
2020THE LATEST : British PM Johnson tests negative for virus
AQ
2020JOHNSON & JOHNSON : Southampton Professor to lead Janssen COVID-19 vaccine trial
AQ
2020JOHNSON & JOHNSON : Initiates Second Global Phase 3 Clinical Trial of its Jansse..
AQ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on JOHNSON & JOHNSON